1
|
Bertoni S, Simone E, Sangiorgi S, Albertini B, Passerini N. The use of polymorphic state modifiers in solid lipid microparticles: The role of structural modifications on drug release performance. Eur J Pharm Sci 2024; 192:106650. [PMID: 37995834 DOI: 10.1016/j.ejps.2023.106650] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 10/18/2023] [Accepted: 11/20/2023] [Indexed: 11/25/2023]
Abstract
This study investigates the correlation between the structural and release properties of solid lipid microparticles (MPs) of tristearin containing 5 % w/w of four different liquid additives used as crystal modifiers: isopropyl myristate (IM), ethyl oleate (EO), oleic acid (OA) and medium chain triglycerides (MCT). All additives accelerated the conversion of the unstable α-form of tristearin, formed after the MPs manufacturing, to the stable β-polymorph and the transformation was completed within 24 h (for IM and EO) or 48 h (for OA and MCT). The kinetic of polymorphic transition at 25 °C was investigated by simultaneous synchrotron SAXS/WAXS and DSC analysis after melting and subsequent cooling of the lipid mixture. After crystallization in the α-phase, additives accelerate the solid-solid phase transformation to β-tristearin. SAXS data showed that two types of structural modifications occurred on MPs during storage: compaction of the crystal packing (slight decrease in lamellar thickness) and crystal growth (increased number of stacked lipid lamellae). The release behavior of a model hydrophilic drug (caffeine) at two different amounts (15 % and 30 %) from MPs was studied in water and biorelevant media simulated the gastric and intestinal environment. It was particularly significant that the introduction of IM, EO and MCT were able to prolong the drug release in water, passing from a diffusion-based Higuchi kinetics to a perfect zero-order kinetic. Moreover, the overall release profiles were higher in biorelevant media, where erosion/digestion of MPs was observed. After 6 months, a moderate but statistically significant change in release profile was observed for the MPs with IM and EO, which can be correlated with the time-dependent structural alterations (i.e. larger average crystallite size) of these formulations; while MPs with OA or MCT displayed stable release profiles. These findings help to understand the correlation between release behavior, polymorphism and supramolecular-level structural modification of lipid formulations containing crystal modifiers.
Collapse
Affiliation(s)
- Serena Bertoni
- Department of Pharmacy and Biotechnology, University of Bologna, Via S. Donato 19/2, Bologna 40127, Italy
| | - Elena Simone
- Department of Applied Science and Technology, Politecnico di Torino, Torino 10129, Italy
| | - Stefano Sangiorgi
- Department of Pharmacy and Biotechnology, University of Bologna, Via S. Donato 19/2, Bologna 40127, Italy
| | - Beatrice Albertini
- Department of Pharmacy and Biotechnology, University of Bologna, Via S. Donato 19/2, Bologna 40127, Italy.
| | - Nadia Passerini
- Department of Pharmacy and Biotechnology, University of Bologna, Via S. Donato 19/2, Bologna 40127, Italy
| |
Collapse
|
2
|
Schertel S, Corzo C, Leitner L, Karrer J, Engel D, Teichmann Y, Zimmer A, Salar-Behzadi S. Going green: Development of a sustainable lipid-based enteric coating formulation for low-dose aspirin multiparticulate systems. Int J Pharm 2022; 614:121453. [PMID: 35021045 DOI: 10.1016/j.ijpharm.2022.121453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2021] [Revised: 01/01/2022] [Accepted: 01/04/2022] [Indexed: 11/17/2022]
Abstract
There is a rising awareness of pharmaceutical industry of both patient-centric and sustainable product development. Manufacturing of multiparticulate systems (MPS) with functional coating via solvent-free hot melt coating (HMC) can fulfill both requirements. An innovative lipid-based formulation was developed with the composition of palmitic acid and Grindsted® citrem BC-FS (BC-FS) for enteric coating of acetylsalicylic acid (ASA). The ASA crystals were directly hot melt coated to produce user-friendly low-dose ASA MPS for thromboembolism prophylaxis. Prior to HMC, rational boundaries for the process temperature were defined based on the melting and crystallization behavior of coating blend. Stability of coating in terms of resistance to heat stress and solidstate stability were screened via Fourier-transform infrared spectroscopy and x-ray diffraction. Exposure of coating blend to 100 °C for two hours did not cause any chemical degradation. Crystal growth of palmitic acid and polymorphic transformation in BC-FS were observed after storage under accelerated conditions, however did not significantly affect the ASA release from coating. The developed formulation is a unique solvent-free, lipid-based enteric composition and paves the way for sustainable green pharmaceutical manufacturing.
Collapse
Affiliation(s)
- Sonja Schertel
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, 8010 Graz, Austria; Hermes Arzneimittel GmbH, Division Hermes Pharma, 82049 Pullach, Germany
| | - Carolina Corzo
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, 8010 Graz, Austria; Research Center Pharmaceutical Engineering GmbH, 8010 Graz, Austria
| | - Lukas Leitner
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, 8010 Graz, Austria; Research Center Pharmaceutical Engineering GmbH, 8010 Graz, Austria
| | - Julia Karrer
- Research Center Pharmaceutical Engineering GmbH, 8010 Graz, Austria
| | - Daniel Engel
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, 8010 Graz, Austria; Research Center Pharmaceutical Engineering GmbH, 8010 Graz, Austria
| | - Yannik Teichmann
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, 8010 Graz, Austria; Research Center Pharmaceutical Engineering GmbH, 8010 Graz, Austria
| | - Andreas Zimmer
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, 8010 Graz, Austria
| | - Sharareh Salar-Behzadi
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, 8010 Graz, Austria; Research Center Pharmaceutical Engineering GmbH, 8010 Graz, Austria.
| |
Collapse
|
3
|
Schertel S, Salar-Behzadi S, Karrer J, Laggner P, Zimmer A. Impact of polysorbate 65 on tripalmitin crystal growth and release stability of hot melt coated multiparticulate systems. Int J Pharm 2021; 607:120970. [PMID: 34363917 DOI: 10.1016/j.ijpharm.2021.120970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Revised: 07/20/2021] [Accepted: 07/30/2021] [Indexed: 11/29/2022]
Abstract
Hydrochlorothiazide (HCT) multiparticulate systems (MPS) were hot melt coated with the binary mixture of tripalmitin (PPP) and polysorbate 65 (PS 65) to gain an immediate release profile. Once, HCT MPS were produced with a constant ratio of PPP/PS 65 (90:10) at three different coating amounts (15, 25, and 60%w/w) and once the PPP/PS 65 ratio was varied on 98:2 and 80:20, by keeping the coating amount at 60%w/w. PS 65 induced the polymorphic transformation of PPP from the α-form to its most stable β-form right after the hot melt coating (HMC). A release alteration of HCT, either accelerated or decelerated, occurred after the storage under accelerated conditions. The effect of the API core on the lipid lamellar configuration, the thermal behavior of lipid coating, and the effect of PS 65 concentration on the crystal growth of PPP were investigated via X-ray diffraction and DSC. While a low amount of PS 65 was sufficient to promote crystal growth of PPP and resulted in a decelerated release of HCT from the coating, a higher PS 65 concentration favored phase separation of PPP and PS 65 and led to an accelerated release. The increase in PS 65 reinforced the molecular interaction with the lipophilic HCT, reflected in less crystal growth and decelerated release. The knowledge presented in this study supports understanding the instability of binary emulsifier-lipid coating systems, paving the way for developing robust HMC formulations.
Collapse
Affiliation(s)
- Sonja Schertel
- Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, University of Graz, 8010 Graz, Austria; Hermes Arzneimittel GmbH, Division Hermes Pharma, 82049 Pullach, Germany
| | - Sharareh Salar-Behzadi
- Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, University of Graz, 8010 Graz, Austria; Research Center for Pharmaceutical Engineering GmbH, 8010 Graz, Austria
| | - Julia Karrer
- Research Center for Pharmaceutical Engineering GmbH, 8010 Graz, Austria
| | - Peter Laggner
- Research Center for Pharmaceutical Engineering GmbH, 8010 Graz, Austria
| | - Andreas Zimmer
- Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, University of Graz, 8010 Graz, Austria.
| |
Collapse
|